Fact CheckerSign in

NCT06358885Active, not recruiting

IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention

IGHID 12230 - Scaling up the Brief Alcohol Intervention to Prevent HIV Infection in Vietnam: a Cluster Randomized, Implementation Trial (EBAI)

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

This study is a hybrid type 3, cluster randomized implementation trial to examine effective strategies to scale up the Brief Alcohol Intervention (BAI) in ART clinics in Vietnam. One arm will receive only facilitation for BAI implementation. Facilitation is a flexible strategy that helps clinics to address common barriers, such as counselor skills, competing priorities, and resource deficits. In the other arm, in addition to facilitation, clinic staff, irrespective of their own alcohol use, will be offered the BAI themselves as experiential learning (EBAI) to address their own alcohol-related attitudes and behaviors. Clinic staff responsible for delivering the BAI to patients will also be offered 3 consolidation activities to integrate their own experiences with their delivery of the BAI.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
3234 (actual)
First submitted
1 Apr 2024
Start date
25 Apr 2024
Primary completion date
Nov 2026
Lead sponsor
University of North Carolina, Chapel Hill
Diseases
HIV
NCT number
NCT06358885

What you commit to

  • Study type: Interventional
  • Participants enrolled: 3234
  • From 25 Apr 2024 to the primary completion date, Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment
  • Psychological disturbance, cognitive impairment, or threatening behavior

Other

  • PWH cohort participants:
  • Psychological disturbance preventing participation
  • Threatening behavior
  • Unwilling to provide locator information Note: If a participant screens positive with the AUDIT-C and is identified to be at substantial risk for alcohol withdrawal based on the Mini International Neuropsychiatric Interview (MINI) and Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) will be referred for treatment. They will not be eligible for enrollment until after alcohol withdrawal concerns are addressed.
  • These participants may be rescreened, consented, and enrolled after treatment.
    • Clinic staff participants:

Who the study is looking for

  • PWH cohort participants
  • Person living with HIV at any stage of HIV infection
  • Currently attending the study ART clinic at any ART stage (initiating or receiving ART)
  • AUDIT-C score \>=4 for men or \>=3 for women
  • \>= 18 years of age
  • Willing to provide informed consent, which includes consenting to interview and collection of dried blood spots
    • Clinic staff participants:
  • Work at the ART clinic as a clinic director, physician, nurse, or counselor
  • Willing to provide informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hanoi Medical University
Coordinator of this site? Confirm its status
HanoiVietnamUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.